Meeting Details

The 18th Annual General Meeting of Supriya Lifescience Limited was held on Thursday, September 24, 2026, at 3:00 PM IST through Video Conferencing/Other Audio-Visual Means (VC/OAVM). The meeting commenced at 3:00 PM and concluded at 3:50 PM IST. The registered office at 207/208, Udyog Bhavan, Sonawala Road, Goregaon (East), Mumbai – 400 063 was deemed as the venue in accordance with MCA and SEBI circulars.

Proposed Resolutions and Implications

Five ordinary business items were transacted:

1. To receive, consider, approve and adopt the Audited Financial Statements for FY ended March 31, 2026, with Board of Directors and Auditors' reports

2. To declare a Final Dividend of ₹1.00 (50%) per Equity Share of ₹2 each for FY 2025-26

3. To reappoint Dr. Saloni Wagh (DIN: 08491410) who retires by rotation under Section 152(6) of Companies Act, 2013

4. To ratify remuneration of Cost Auditors for FY 2026-27

5. To reappoint Ms. Shivani Wagh (DIN: 08491420) who retires by rotation under Section 152(6) of Companies Act, 2013

Voting Process and Methods

The company provided remote e-voting facility through National Securities Depository Limited (NSDL) from 9:00 AM on Monday, September 21, 2026, to 5:00 PM on Wednesday, September 23, 2026. Members could also vote electronically during the AGM. The cut-off date for determining voting rights was Thursday, September 17, 2026. The company appointed M/s. DSM & Associates, Practicing Company Secretaries, as scrutinizer for the voting process.

Key Voting Outcomes

Resolution 1: Adoption of Financial Statements

  • Total votes cast: 5,83,44,934
  • Votes in favor: 5,83,43,414 (99.9974%)
  • Votes against: 1,520 (0.0026%)

Resolution 2: Final Dividend Declaration

  • Total votes cast: 5,83,44,944
  • Votes in favor: 5,83,43,389 (99.9973%)
  • Votes against: 1,555 (0.0027%)

Resolution 3: Reappointment of Dr. Saloni Wagh

  • Total votes cast: 5,81,40,184
  • Votes in favor: 5,80,01,856 (99.7621%)
  • Votes against: 1,38,328 (0.2379%)

Resolution 4: Ratification of Cost Auditors' Remuneration

  • Total votes cast: 5,83,44,944
  • Votes in favor: 5,83,42,775 (99.9963%)
  • Votes against: 2,169 (0.0037%)

Resolution 5: Reappointment of Ms. Shivani Wagh

  • Total votes cast: 5,53,67,537
  • Votes in favor: 5,53,65,235 (99.9958%)
  • Votes against: 2,302 (0.0042%)

Participation Breakdown

  • Total shareholders on record date (September 4, 2026): 80,126
  • Shareholders attending meeting through VC: 6
  • Promoters and promoter group attending: 51

Scrutinizer's Role and Findings

CS Sanam Umbargikar of M/s. DSM & Associates was appointed as scrutinizer. The scrutinizer verified that:

  • NSDL was engaged as service provider for remote e-voting and e-voting at AGM
  • Notice of AGM with Annual Report was dispatched by email on September 1, 2026, to all members with registered email IDs
  • Advertisement was published in Financial Express (English) and Loksatta (Marathi) on August 27, 2026
  • Remote e-voting portal was blocked at 5:00 PM on September 23, 2026
  • Results were unblocked and downloaded after the AGM
  • All resolutions were passed with requisite majority

Compliance Confirmation

The disclosure confirms compliance with:

  • Regulation 30 and 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
  • Section 108 of Companies Act, 2013
  • Rule 20 of Companies (Management and Administration) Rules, 2014
  • Various circulars issued by MCA and SEBI

Additional Information

The voting results and scrutinizer's report were uploaded on the company's website (www.supriyalifescience.com) and NSDL's website (www.evoting.nsdl.com). The company's CIN is L51900MH2008PLC180452 and scrip codes are 543434 (BSE) and SUPRIYA (NSE).